Oral dosage form safeguarded against abuse containing (1R, 2R)-3-(3-dimethylamino-1-ethyl-2-meth yl-propyl)-phenol
Details for Australian Patent Application No. 2005259478 (hide)
International Classifications
Event Publications
22 February 2007 PCT application entered the National Phase
PCT publication WO2006/002886 Priority application(s): WO2006/002886
22 March 2007 Change of Name(s) of Applicant(s), Section 104
Grunenthal GmbH The name of the applicant has been changed to Gruenenthal GmbH
10 April 2008 Amendment Made
The nature of the amendment is: Amend the name of the inventor to include co-inventor Arkenau-Maric, Elisabeth 2006
15 July 2010 Application Accepted
Published as AU-B-2005259478
11 November 2010 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2005259481-Improved adjuvant therapy of G250-expressing tumors
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser